SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Samrat Pharmachem

Samrat Pharmachem

BSE: 530125 | NSE: | ISIN: INE103E01016 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Mar 05, 16:00
25.05
-0.05 (-0.20%)
VOLUME 151
AVERAGE VOLUME
5-Day 522
10-Day 779
30-Day 1,461
VOLUME SHOCKER
5-Day 522
10-Day 779
30-Day 1,461
Prev. Close
25.10
Open Price
27.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 23.70 27.00
52 Wk Low/High 16.95 34.35

Samrat Pharma is not listed on NSE

No recommendations so far.

What's your call on Samrat Pharma today?
Read 1 investor views

Standalone
MARKET CAP (Rs Cr)
7.74
*P/E
10.61
*BOOK VALUE (Rs)
42.52
DIV (%)
0.00%
Market Lot
1
INDUSTRY P/E
27.03
*EPS (TTM)
2.36
*P/C
7.28
*PRICE/BOOK
0.59
DIV YIELD.(%)
-%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
99.80 new
DELIVERY AVERAGES
3-Day 99.58%
5-Day 96.74%
8-Day 75.28%
* Based on standalone numbers
Track Samrat Pharma on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

4 March 2015

buy

RelCapital Mar Fut

Entry Price (Rs)

476.00

Exit Price (Rs)

485.00

Gain (Rs)

9.00

buy

IndusIndBank Mar Fut

Entry Price (Rs)

946.00

Exit Price (Rs)

957.00

Gain (Rs)

11.00

buy

Glenmark Mar Fut

Entry Price (Rs)

805.00

Exit Price (Rs)

818.00

Gain (Rs)

13.00

buy

NIFTY Mar Fut

Entry Price (Rs)

9,035.00

Exit Price (Rs)

9,085.00

Gain (Rs)

50.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 20.20 27.00  
High Price 22.25 27.00  
Low Price 20.15 23.70  
Last Price 20.15 25.05 24.32
Volume 2,311 151 -93.47
Simple Moving Averages
Days BSE NSE
30 26.04
50 26.48
150 26.43
200 25.15

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Samrat Pharma

News/Videos & Announcements
Stock Advice & Research Reports
Stock Advice
No Advice
Research Reports
No Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
 Standalone (Dec '14)
(Sep '14)
Net Sales 8.99 15.09
Other Income 0.04 0.06
PBDIT 0.26 0.54
Net Profit 0.00 0.14

Annual Report

Download in PDF format 2014 |2013 |2012 |2011 |2010
Balance Sheet
(Sep '14)
(In Rs Cr)
Total Share Capital 3.09
Net Worth 13.14
Total Debt 3.15
Net Block 7.51
Investments 0.00
Net Current Assets 8.77
Total Assets 16.28
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 1037.35 3.24 1037.35 552.50 214,852.19
Lupin 1838.30 3.22 1838.30 928.80 82,605.80
Cipla 737.85 1.81 746.50 385.00 59,246.44
Dr Reddys Labs 3439.45 1.48 3662.00 2250.00 58,601.26
Ranbaxy Labs 805.65 3.00 805.65 353.00 34,293.58
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Dec' 14Jun' 14Mar' 14Dec' 13
Promoter46.9846.7846.7846.78
FII3.243.243.243.24
DII0.000.000.000.00
Others49.7849.9849.9849.98
Total100.00100.00100.00100.00
Mutual Funds Holding
No Mutual Funds Holding the share
Company Information
REGISTERED OFFICE
Address
Plot No A2/3445, GIDC, Phase IV ,
City
Ankleshwar
State
Gujarat
Pin Code
393002
Tel. No.
02646-220774 02646-251291
Fax No.
02646-251291
REGISTRARS
Name
Link Intime India Pvt. Ltd.
Address
C-13, Pannalal Silk Mills Compound, LBS Marg, Bhandup (W)
City
Mumbai - 400078
State
Maharashtra
Tel. No.
022-25963838, 25946970
Fax No.
022-25946969
MANAGEMENT
Name
Designation
Lalit Mehta
Chairman & Managing Director
Rajesh Mehta
Executive Director & CFO
Mahendra Pipalia
Director
Samir Kothary
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Gabriel India Recommended on Nov 5th 2014

Recommended price 83.00  |  Peak from reco 106.75 28.00%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Samrat Pharma

Samrat Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 7.74 crore.The company has reported a standalone sales of Rs 8.99 crore and a Net Profit of Rs 0.00 crore for the quarter ended Dec 2014.

The company management includes Lalit Mehta - Chairman & Managing Director, Rajesh Mehta - Executive Director & CFO, Mahendra Pipalia - Director, Samir Kothary - Director.

It is listed on the BSE with a BSE Code of 530125.

Its Registered office is at Plot No A2/3445, GIDC, Phase IV , Ankleshwar,Gujarat - 393002.

Their Registrars are Link Intime India Pvt. Ltd.

Quick Links for Samrat Pharmachem
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Samrat Pharma